S Polakoff

Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia

Twelve-Month Use of Mental Health Services in the United States

Electrophysiology of the 5-HT1A ligand MDL 73005EF in the rat hippocampal slice

Motives for Nonsuicidal Self-Injury Among Women With Borderline Personality Disorder

Hypersexual Disorder: A Proposed Diagnosis for DSM-V

Empathy: Its ultimate and proximate bases

Optimal Dose of Neuroleptic in Acute Schizophrenia

Autism: Towards an Integration of Clinical, Genetic, Neuropsychological, and Neurobiological Perspectives

THE NEUROBIOLOGY OF IMPULSIVE AGGRESSION

Speech Acquisition in Older Nonverbal Individuals With Autism

PSYCHOPHARMACOLOGIC TREATMENT OF PATHOLOGIC AGGRESSION

Autism and emotion: An ethological theory.

Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

Paroxetine: A Selective Serotonin Reuptake Inhibiting Antidepressant

A review of central 5-HT receptors and their function

Psychiatric Aspects of Impulsivity

Opiate mechanisms in self‐injury

Minimally Verbal School‐Aged Children with Autism Spectrum Disorder: The Neglected End of the Spectrum

Central Serotonin and Impulsive Aggression

Helping clients forgive: An empirical guide for resolving anger and restoring hope.

Recent Advances in the Pharmacotherapy of Autism and Related Conditions

Prescribed drugs containing nitrogen heterocycles: an overview

Brief report: Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults

Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study.

Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia

Autism: the treatment of aggressive behaviors.

??-Blockers in the Severely and Profoundly Mentally Retarded